Greek Pharmaceuticals Regulator Temporarily Bans Parallel Exports, Stockpiling of Five Vaccines for Children

Greece’s National Organisation for Medicines issued a temporary ban of parallel exports, stockpiling or intra-Community trade of five brands of children’s vaccines guarding against hepatitis and whooping-cough, in order to ensure an adequate domestic supply.

The ban is for the vaccines marketed under the names Repevax (booster shot against diptheria, tetanus, whooping-cough and polio), Engerix (hepatitis B), Hbvaxpro (hepatitis B), Havrix (hepatitis A) and Vaqta (hepatitis A).

The decision bans parallel trade and stock piling of the products and obliges all participants in the distribution chain to supply the domestic market as a priority, based on demand and prescriptions, until the temporary ban is either rescinded or amended.


You may also like...

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.